Meritain Eldorado policies, page 15

Search Meritain Eldorado's public medical, payment and drug policies by CPT or HCPCS code, keyword or policy number, with links to the payer's own documents. Links open the payer's own document; check its current version before relying on it.

5,481 public policies Substrate tracks for Meritain Eldorado, by title.

Meritain Eldorado policies
PolicyDetailsCodesSource
[Pharmacy] Anadrol-50 PA Policy 1087-A 01-2022 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan1087-A · Commercial—Original policy ↗
[Pharmacy] Anadrol-50 PA Policy 1087-A 01-2022 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan1087-A · Commercial—Original policy ↗
[Pharmacy] Anadrol-50 PA Policy 1087-A 01-2022 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan1087-A · Commercial—Original policy ↗
[Pharmacy] Anadrol-50 PA Policy 1087-A 01-2022 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan1087-A · Commercial—Original policy ↗
[Pharmacy] Anadrol-50 PA Policy 1087-A 01-2022 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan1087-A · Commercial—Original policy ↗
[Pharmacy] Anorexigenic Agents Supplemental Indications Only PA with Limit 6410-C P08-2024 v5 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan6410-C · Commercial—Original policy ↗
[Pharmacy] Anorexigenic Agents Supplemental Indications Only PA with Limit 6410-C P08-2025 v3 - Specialty Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan6410-C · Commercial—Original policy ↗
[Pharmacy] Anticholinergic, Combination, Mast Cell Stabilizer Oral Inhalation Limit 139-H P09-2024_R - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan139-H · Commercial—Original policy ↗
[Pharmacy] Anticholinergic, Combination, Mast Cell Stabilizer Oral Inhalation Limit 139-H P09-2025 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan139-H P09-2025 · Commercial—Original policy ↗
[Pharmacy] Anticholinergic, Combination, Mast Cell Stabilizer Oral Inhalation Limit Policy 139-H 10-2023 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan139-H · Commercial—Original policy ↗
[Pharmacy] Anticholinergic,Combination,MastCellStabilizer Oral Inhalation Limit Policy 139-H 01-2022 - Specialty Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan139-H · Commercial—Original policy ↗
[Pharmacy] Anticholinergic,Combination,MastCellStabilizer Oral Inhalation Limit Policy 139-H 01-2023 - Specialty Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan139-H · Commercial—Original policy ↗
[Pharmacy] Antidiabetic Agents ST, Post PA 676-D 08-2022 - Specialty Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan676-D · Commercial—Original policy ↗
[Pharmacy] Antidiabetic Agents ST, Post PA 676-D P05-2025 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan676-D · Commercial—Original policy ↗
[Pharmacy] Antidiabetic Agents ST, Post PA 676-D P05-2025 v2 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan676-D · Commercial—Original policy ↗
[Pharmacy] Antidiabetic Agents ST, Post PA 676-D P05-2025 v3 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan676-D · Commercial—Original policy ↗
[Pharmacy] Antidiabetic Agents ST, Post PA Policy 676-D UDR 05-2023 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan676-D · Commercial—Original policy ↗
[Pharmacy] Antidiabetic Agents ST, Post PA Policy 676-D UDR 05-2023 v2 - Specialty Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan676-D · Commercial—Original policy ↗
[Pharmacy] Antidiabetic Agents ST, Post PA Policy 676-D, BOG 6332-D UDR 05-2024 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan676-D · Commercial—Original policy ↗
[Pharmacy] Antidiabetic Agents ST, Post PA Policy 676-D, BOG 6332-D UDR 05-2024 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan676-D · Commercial—Original policy ↗
[Pharmacy] Antidiabetic GLP-1, GIP-GLP-1 Agonist Limit 4525-H P05-2025 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan4525-H · Commercial—Original policy ↗
[Pharmacy] Antidiabetic GLP-1, GIP-GLP-1 Agonist Limit 4525-H P05-2025 v3 - Specialty Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan4525-H · Commercial—Original policy ↗
[Pharmacy] Antidiabetic GLP-1, GIP-GLP-1 Agonist Limit Policy 4525-H 05-2023 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan4525-H · Commercial—Original policy ↗
[Pharmacy] Antidiabetic GLP-1, GIP-GLP-1 Agonist Limit Policy 4525-H 05-2024 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan4525-H · Commercial—Original policy ↗
[Pharmacy] Antidiabetic GLP-1, GIP-GLP-1 Agonist Limit Policy 4525-H 08-2021 v3 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan4525-H · Commercial—Original policy ↗
[Pharmacy] Antidiabetic GLP-1, GIP-GLP-1 Agonist Limit Policy 4525-H 08-2022 v2 - Specialty Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan4525-H · Commercial—Original policy ↗
[Pharmacy] Antidiabetic GLP-1, GIP-GLP-1 Agonist PA with Limit 2439-C P05-2025 - Specialty Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2439-C · Commercial—Original policy ↗
[Pharmacy] Antidiabetic GLP-1, GIP-GLP-1 Agonist PA with Limit 2439-C P05-2025 v2 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2439-C · Commercial—Original policy ↗
[Pharmacy] Antidiabetic GLP-1, GIP-GLP-1 Agonist PA with Limit 2439-C P05-2025 v2 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2439-C · Commercial—Original policy ↗
[Pharmacy] Antidiabetic GLP-1, GIP-GLP-1 Agonist PA with Limit 2439-C P05-2025 v4 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2439-C · Commercial—Original policy ↗
[Pharmacy] Antidiabetic GLP-1, GIP-GLP-1 Agonist PA with Logic 5694-D P05-2025 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan5694-D · Commercial—Original policy ↗
[Pharmacy] Antidiabetic GLP-1, GIP-GLP-1 Agonist PA with Logic Policy 5694-D UDR 05-2023 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan5694-D · Commercial—Original policy ↗
[Pharmacy] Antidiabetic GLP-1, GIP-GLP-1 Agonist PA with Logic Policy 5694-D UDR 05-2024 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan5694-D · Commercial—Original policy ↗
[Pharmacy] Antiemetic 5-HT3 Post Limit PA 16-J P01-2025 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan16-J P01-2025 · Commercial—Original policy ↗
[Pharmacy] Antiemetic 5-HT3 Post Limit PA Policy 16-J 01-2023 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan16-J · Commercial—Original policy ↗
[Pharmacy] Antiemetic 5-HT3 Post Limit PA Policy 16-J UDR 01-2024 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan16-J UDR 01-2024 · Commercial—Original policy ↗
[Pharmacy] Antiemetic 5-HT3 Post Limit PA REG 2821-J 01-2024 v2_R - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2821-J · Commercial—Original policy ↗
[Pharmacy] Antiemetic 5-HT3 Post Limit PA REG 2821-J 01-2024 v2_R - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2821-J · Commercial—Original policy ↗
[Pharmacy] Antiemetic NK1 Limit 78-H P01-2025 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan78-H P01-2025 · Commercial—Original policy ↗
[Pharmacy] Antiemetic NK1 Limit Policy 78-H 01-2024 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan78-H · Commercial—Original policy ↗
[Pharmacy] Antiemetic NK1 Limit Policy 78-H UDR 01-2023 v2 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan78-H · Commercial—Original policy ↗
[Pharmacy] Antiemetic NK1 Post Limit PA 79-J P01-2025 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan79-J · Commercial—Original policy ↗
[Pharmacy] Antiemetic NK1 Post Limit PA 79-J P01-2025 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan79-J · Commercial—Original policy ↗
[Pharmacy] Antiemetic NK1 Post Limit PA 79-J P01-2026 v3 - Specialty Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan79-J · Commercial—Original policy ↗
[Pharmacy] Antiemetic NK1 Post Limit PA Policy 79-J UDR 01-2023 v2 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan79-J · Commercial—Original policy ↗
[Pharmacy] Antiemetic NK1 Post Limit PA Policy 79-J UDR 01-2024 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan79-J · Commercial—Original policy ↗
[Pharmacy] Antifungal Topical Combinations Limit, Post PA Policy 2912-HJ 04-2022 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2912-HJ · Commercial—Original policy ↗
[Pharmacy] Antifungal Topical Combinations Limit, Post PA Policy 2912-HJ UDR 04-2023 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2912-HJ · Commercial—Original policy ↗
[Pharmacy] Antifungal Topical Combinations Limit, Post PA Policy 2912-HJ UDR 04-2024 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2912-HJ · Commercial—Original policy ↗
[Pharmacy] Antifungal Topical Combinations Limit, Post PA Policy 2912-HJ UDR 04-2024 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2912-HJ · Commercial—Original policy ↗

Back to Meritain Eldorado

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.